Menu Back to Global-Forum-for-Qualified-Persons-for-Pharmacovigilance-QPPV

Overview

In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now celebrating its 16th year and still going strong.

Back in a face-to-face format, it brings together QPPVs from all over the world to discuss how to harmonise international QPPV roles. Key trends requiring QPPV awareness, input and oversight are discussed in a high-level and neutral approach.

This year’s objectives have been shaped by feedback provided by participants from the past 15 meetings. We will discuss pragmatic approaches to modern technology and how this will impact the QPPV role in multiple regions.

The Forum is continually supported by key regulators and lives from interaction. Take this opportunity to raise questions and bring your challenging issues to the group in an informal and interactive environment.


Featured Topics

  • Keynote: 10 Years of Strengthened EU Pharmacovigilance
  • International Pharmacovigilance
  • Hackathon - Build On The International Piece: What can we do to have harmonization around the globe?
  • Pharmacovigilance System Oversight
  • Regulators – Inspection Feedback
  • True Adverse Reaction or Not: That’s the Question
  • Hot Topics: Bitesized Updates
  • QPPV Talks

Why should you attend this conference?

Who should attend?

  • Global QPPVs/ Deputies
  • Regulators
  • Pharmacovigilance Consultants
  • Directors of Pharmacovigilance Oversight and Standards
  • Drug Safety Managers/Leaders
  • Auditors
  • Medical and Regulatory Affairs Experts
  • Aspiring PV Specialists/QPPVs

Learning objectives

  • Hear the latest updates and hot topics relating to the role of the QPPV
  • Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of the QPPV
  • Network with colleagues and meet regulators
  • Learn from and share experience and ideas with like-minded QPPVs in a neutral environment
  • Better understand regulatory and inspectorate expectations globally
  • Examine current challenges and share potential solutions

Program Committee

  • Angela  Van Der Salm, PhD, MSc
    Angela Van Der Salm, PhD, MSc Director Pharmacovigilance, Managing partner
    DADA Consultancy BV, Netherlands
  • Magnus  Ysander, MD
    Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
    AstraZeneca, Sweden
  • Shahinaz  Badr
    Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
    Pharma Quality Europe, United Arab Emirates
  • Vicki  Edwards, RPh
    Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
    AbbVie, Inc., United Kingdom
  • Gemma  Jimenez Sese
    Gemma Jimenez Sese Patient Safety Director, EU QPPV
    Almirall, S.A., Spain
  • Maarten  Lagendijk, MSc
    Maarten Lagendijk, MSc Deputy EU QPPV
    MSD, Netherlands
  • Elspeth  McIntosh, MBA, RN
    Elspeth McIntosh, MBA, RN Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Katarzyna  Swiderek, MPharm, RPh
    Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
    GlaxoSmithKline, Poland
  • Kiernan  Trevett, MSc
    Kiernan Trevett, MSc Principal Quality Lead, PDQ Quality Assurance Process GVP
    Roche, United Kingdom
  • Sophie  Radicke, MSc
    Sophie Radicke, MSc Head of GPvP and Senior Pharmacovigilance Inspector
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Nicolas  Tsiakkas, MD
    Nicolas Tsiakkas, MD Scientific Director
    Medwork Pharma Research & Consulting, Greece
  • Willemijn  van der Spuij, MSc
    Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
    Bristol-Myers Squibb, Switzerland
Load More

Contact us

Registration Questions?

Send Email
+41 61 225 51 51

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download